Analysts’ Perspective: CarMax (KMX), Bank of Montreal (BMO), Tenax Therapeutics (TENX)

CarMax Inc. (NYSE:KMX) shares were upgraded by analysts at Wedbush from Neutral to Outperform rating while increasing their price target from $60 to $70.

CarMax Inc., through its subsidiaries, operates as a retailer of used vehicles in the United States.


Brokerage Firm Citigroup upgraded Bank of Montreal (NYSE:BMO) shares from Neutral to Buy rating.

Bank of Montreal provides diversified financial services primarily in North America.


Investment Analysts at Ladenburg Thalmann upgraded Tenax Therapeutics, Inc. (NASDAQ:TENX) shares from Neutral to Buy rating.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at